Compare JBSS & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBSS | INNV |
|---|---|---|
| Founded | 1959 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical/Nursing Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 1994 | 2021 |
| Metric | JBSS | INNV |
|---|---|---|
| Price | $86.47 | $11.88 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $109.00 | $7.00 |
| AVG Volume (30 Days) | 102.5K | ★ 432.0K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | ★ $1,107,246,000.00 | $853,699,000.00 |
| Revenue This Year | $5.58 | $12.85 |
| Revenue Next Year | N/A | $8.88 |
| P/E Ratio | $18.38 | ★ N/A |
| Revenue Growth | 3.79 | ★ 11.76 |
| 52 Week Low | $59.07 | $3.13 |
| 52 Week High | $92.08 | $12.64 |
| Indicator | JBSS | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 69.14 |
| Support Level | $74.42 | $7.33 |
| Resistance Level | $92.08 | $12.64 |
| Average True Range (ATR) | 2.78 | 0.75 |
| MACD | -0.53 | -0.07 |
| Stochastic Oscillator | 29.62 | 66.67 |
John B Sanfilippo & Son Inc is one of the processors and distributors of peanuts, pecans, cashews, walnuts, almonds, and other nuts in the United States. These nuts are sold under a variety of private brands and the Fisher, Orchard Valley Harvest, and Sunshine Country brand names. It also markets and distributes, and in the majority of cases, manufactures or processes, a diverse product line of food and snack products, including peanut butter, almond butter, cashew butter, candy and confections, snacks and trail mixes, snack bites, sunflower kernels, dried fruit, corn snacks, sesame sticks and other sesame snack products under private brands and brand names.
InnovAge Holding Corp is a healthcare delivery platform comprising multiple participants focused on providing all-inclusive, capitated care to high-cost seniors, many of whom are dual-eligible. Its programs are designed to address two of the pressing challenges facing the U.S. healthcare industry: rising costs and poor outcomes. The purpose of the participant-centered care delivery approach is to improve the quality of care participants receive, while keeping them in their homes for as long as possible and reducing the overutilization of high-cost care settings, such as hospitals and nursing homes. The company manages its business as one reportable segment, PACE.